Longitudinal changes in quality of life and costs in long-term survivors of tumors of the oropharynx treated with brachytherapy or surgery

Brachytherapy

Volumn 7, Issue 4, 2008, Pages 343-350

  Nijdam, Wideke M ^a   Levendag, Peter C ^a   Noever, Inge ^a   Schmitz, Paul I M ^a   Uyl de Groot, Carin A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Brachytherapy; Costs; Oropharyngeal cancer; Quality of life; Surgery

Indexed keywords

ADULT; ARTICLE; BRACHYTHERAPY; CALCULATION; CANCER SURVIVOR; DIET; EATING; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CANCER; PERFORMANCE MEASUREMENT SYSTEM; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; QUESTIONNAIRE; SPEECH; XEROSTOMIA;

ADULT; AGED; BRACHYTHERAPY; FEMALE; HEALTH SURVEYS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; ORAL SURGICAL PROCEDURES; OROPHARYNGEAL NEOPLASMS; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; SURVIVORS;

EID: 53349161921     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2008.05.001     Document Type: Article

References (27)

1. Fu K.K., Pajak T.F., Trotti A., et al. A Radiation Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48 (2000) 7-16
2. Levendag P.C., Nijdam W.M., van de Pol M., et al. Brachytherapy versus Surgery in carcinoma of the tonsillar fossa and/or soft palate: late normal tissue sequelae and performance status. Can we be more selective?. Int J Radiat Oncol Biol Phys 59 (2004) 713-724
3. Levendag P.C., Schmitz P.I.M., Jansen P.P., et al. Fractionated high-dose-rate and pulsed-dose-rate brachytherapy: first clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palate. Int J Radiat Oncol Biol Phys 38 (1997) 497-506
4. O'Sullivan B., Warde P., Grice B., et al. The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region. Int J Radiat Oncol Biol Phys 51 (2001) 332-342
5. Parsons J.T., Mendenhall W.M., Stringer S.P., et al. Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both. Cancer 94 (2002) 2967-2980
6. Withers H.R., Peters L.J., Taylor J.M.G., et al. Late normal tissue sequelae from radiation therapy for carcinoma of the tonsil: patterns of fractionation, study of radiobiology. Int J Radiat Oncol Biol Phys 33 (1995) 563-568
7. Withers H.R., Peters L.J., Taylor J.M.G., et al. Local control of carcinoma of the tonsil by radiation therapy: an analysis of patterns of fractionation in nine institutions. Int J Radiat Oncol Biol Phys 33 (1995) 549-562
8. Calais G., Bardet E., Sire C., et al. Radiotherapy with concomitant weekly docetaxel for stages III/IV oropharynx carcinoma. Results of the 8-02 Gortec phase II trial. Int J Radiat Oncol Biol Phys 58 (2004) 161-166
9. Levendag P.C., Nijdam W.M., van Agthoven M., et al. Chemotherapy and high-dose-rate brachytherapy in the management of advanced cancers of the nasopharynx: clinical impact of high technology: is it worth the cost?. Brachytherapy 1 (2002) 11-20
10. Nijdam W.M., Levendag P.C., Noever I., et al. Cost analysis comparing brachytherapy versus surgery for primary carcinoma of the tonsillar fossa and/or soft palate. Int J Radiat Oncol Biol Phys 59 2 (2004) 488-494
11. Pol van de M., Levendag P.C., De Bree R.R., et al. Radical radiotherapy compared with surgery for advanced squamous cell carcinoma of the base of tongue. Brachytherapy 3 (2004) 78-86
12. Nijdam W.M., Levendag P.C., Noever I., et al. Cancer in the oropharynx: cost calculation of different treatment modalities for controlled primaries, relapses and grade III/IV complications. Radiother Oncol 77 (2005) 65-72
13. List M., Ritter-Ster C., and Lansky S. A performance status scale for head and neck cancer patients. Cancer 66 (1990) 564-569
14. List M.A., Rutherford J.L., Stracks J., et al. Prioritizing treatment outcomes: head and neck cancer patients versus nonpatients. Head & Neck 26 (2004) 163-170
15. List M.A., Stracks J., Colangelo L., et al. How do head and neck cancer patients prioritize treatment outcomes before initiating treatment. J Clin Oncol 18 (2000) 877-884
16. Aaronson N.K., Ahmedzai S., Bergman B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute 85 (1993) 365-376
17. Bjordal K., Hammerlid E., Ahlner-Elmqvist M., et al. Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clin Oncol 17 (1999) 1008-1019
18. Bjordal K., and Kaasa S. Psychometric validation of the EORTC Core Quality of Life Questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients. Acta Oncol 31 (1992) 311-321
19. Dolan P. Modelling valuations for the EuroQol health states. Med. Care 35 (1997) 1095-1108
20. Wijers O.B., Levendag P.C., Braaksma M.M., et al. Patients with head and neck cancer cured by radiation therapy: a survey of the dry mouth syndrome in long-term survivors. Head & Neck 24 (2002) 737-747
21. Drummond M.F., O'Brien B.J., Stoddart G.L., et al. Methods for the Economic Evaluation of Health Care Programmes (1996), Oxford University Press, New York
22. Gold M.R., Siegel J.E., Russell L.B., et al. Cost-effectiveness in Health and Medicine (1996), Oxford University Press, New York
23. Oostenbrink J.B., Koopmanschap M.A., and Rutten F.F.H. Manual for Costing Research (2000), Health Care Board, Amstelveen (in Dutch)
24. Fang F.M., Chien C.Y., Kuo S.C., et al. Changes in quality of life of head-and-neck cancer patients following postoperative radiotherapy. Acta Oncol 43 (2004) 571-578
25. Hammerlid E., Silander E., Hörnestam L., et al. Health-related quality of life three years after diagnosis of head and neck cancer-a longitudinal study. Head & Neck 23 (2001) 113-125
26. Evans C., Tavakoli M., and Crawford B. Use of quality adjusted life years and life years gained as benchmarks in economic evaluations: a critical appraisal. Health Care Manage Sci 7 (2004) 43-49
27. The Council for Public Health and Health Care (Raad voor de Volksgezondheid & Zorg). Advice on sensible and enduring healthcare ('Zinnige en duurzame zorg'); June 2006 (in Dutch).